Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -39.92M | -34.98M | -29.44M | -23.56M | -23.13M | -20.91M | -21.7M | -22.04M | -19.24M | -18.43M | -15.6M | -14.24M | -11.43M | -9.4M | -8.23M | -27.19M | -26.05M | -24.7M | -24.38M | -2.39M | -2.11M | -2.03M |
Depreciation & Amortization | 487.14K | 436.09K | 364.5K | 315.21K | 206.26K | 150.72K | 115.39K | 77.13K | 52.6K | 28.81K | 5.47K | 2.96K | 2.14K | 2.02K | 2.14K | 2.19K | 2.24K | 22.21K | 22.19K | 22.16K | 22.12K | 2.35K |
Stock-Based Compensation | 2.12M | 1.15M | 570.8K | 705.65K | 1.44M | 2.08M | 3.02M | 3.37M | 3.37M | 3.18M | 2.57M | 1.74M | 1.22M | 888.91K | 624.07K | 516.13K | 364.8K | 279.81K | 214.74K | 92.58K | 30.72K | n/a |
Other Working Capital | -1.85M | -954.11K | -384.74K | 372.54K | 2.64M | 876.64K | 2.66M | 3.16M | -1.77M | -1.49M | -2.98M | -4.91M | -2.05M | -389.72K | -700.15K | -274.42K | -469.29K | -762.22K | -382.64K | 321.4K | 332.91K | 319.41K |
Other Non-Cash Items | 31.03K | 1.03M | 1.87M | 1.87M | 1.4M | 868.36K | n/a | n/a | 1.58M | 1.58M | 1.58M | 1.58M | n/a | n/a | n/a | 22.13M | 22.15M | 22.11M | 23M | 1.45M | 1.43M | 1.33M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.22M | 301.74K | 2.7M | 6.29M | 7.57M | 5.36M | 3.97M | 2.8M | -612.82K | 534.15K | 72.66K | -1.69M | -765.63K | 499.29K | 195.21K | -79.21K | 331.89K | -527.38K | -440.25K | 517.85K | 291.96K | 278.46K |
Operating Cash Flow | -38.5M | -32.07M | -23.93M | -14.38M | -12.51M | -12.45M | -14.6M | -15.8M | -14.85M | -13.11M | -11.37M | -12.6M | -10.97M | -8.01M | -7.41M | -4.62M | -3.21M | -2.82M | -1.59M | -316.28K | -337.24K | -425.19K |
Capital Expenditures | -591.11K | -697.7K | -732.93K | -1.07M | -974.04K | -943.48K | -1.18M | -683.71K | -451.08K | -354.01K | -52.1K | -38.92K | -13 | -13 | -7 | 1 | 2 | 6 | -800 | -804 | -804 | -804 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -18.8M | -14.25M | -6.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 10.24M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -9.15M | -11.95M | -7.21M | -1.07M | -974.04K | -943.48K | -1.18M | -683.71K | -451.08K | -354K | -52.09K | -38.91K | n/a | n/a | n/a | n/a | n/a | n/a | -802 | -802 | -802 | -802 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | -50K | -50K | -50K | 100K | 200K | 200K | 200K | 100K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -44K | -44K | -44K | -44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -95.66K | -166.76K | -166.76K | -166.76K | n/a | n/a | 2.49K | 5.11K | -53.69K | -244.51K | -232K | 233.66K | 292.46K | 483.28K | 468.28K | n/a | -18.35K | -36.02K | -36.02K | -36.02K | -17.67K | n/a |
Financial Cash Flow | 261.52M | 107.35M | 107.39M | 11.72M | 1.11M | n/a | 15.95M | 16.54M | 26.6M | 31.29M | 15.46M | 15.3M | 5.23M | 437.23K | 3.23M | 21.53M | 21.51M | 21.7M | 18.85M | 128.98K | 147.33K | 65K |
Net Cash Flow | 213.85M | 63.33M | 76.25M | -3.74M | -12.34M | -13.4M | 172.16K | 108.01K | 11.32M | 17.86M | 4.07M | 2.67M | -5.75M | -7.6M | -4.21M | 16.88M | 18.29M | 18.88M | 17.46M | 60.26K | 66.88K | -102.93K |
Free Cash Flow | -39.09M | -32.77M | -24.66M | -15.45M | -13.48M | -13.4M | -15.77M | -16.48M | -15.3M | -13.46M | -11.42M | -12.64M | -10.97M | -8.01M | -7.41M | -4.62M | -3.21M | -2.82M | -1.59M | -317.08K | -338.05K | -425.99K |
Adj. Free Cash Flow | -41.21M | -33.92M | -25.23M | -16.16M | -14.92M | -15.47M | -18.79M | -19.85M | -18.67M | -16.64M | -13.99M | -14.38M | -12.19M | -8.89M | -8.03M | -5.13M | -3.57M | -3.1M | -1.8M | -409.67K | -368.77K | -425.99K |
Maintenance CapEx | -279.02K | -337.81K | -364.5K | -315.21K | -206.26K | -150.72K | -115.39K | -77.13K | -52.6K | -28.31K | -4.47K | -1.39K | -13 | -13 | -11 | -11 | -10 | -6 | -612 | -608 | -608 | -608 |
Growth CapEx | -312.1K | -359.89K | -368.42K | -759.74K | -767.78K | -792.76K | -1.06M | -606.58K | -398.47K | -325.7K | -47.63K | -37.53K | n/a | n/a | 4 | 12 | 12 | 12 | -188 | -196 | -196 | -196 |
Owner Earnings | -38.78M | -32.41M | -24.29M | -14.69M | -12.71M | -12.6M | -14.71M | -15.87M | -14.9M | -13.13M | -11.38M | -12.6M | -10.97M | -8.01M | -7.41M | -4.62M | -3.21M | -2.82M | -1.59M | -316.89K | -337.85K | -425.8K |
Add to Watchlist
Select watchlists to add or remove IMMX